Chemical Remodeling of Antimicrobials: Innovative Medicinal Chemistry Strategies to Combat Resistance

Antimicrobial resistance (AMR) has emerged as a major global health challenge, reducing the effectiveness of conventional antibacterial therapies and limiting treatment options for bacterial infections. The continuous emergence of resistant microorganisms highlights the need for innovative approaches to discover new antibacterial agents and improve the activity of existing drugs. Medicinal chemistry and synthetic chemistry provide valuable strategies for addressing AMR through rational drug design, structural optimization, antibiotic adjuvants, combination therapy, drug repurposing, target-directed approaches, and semisynthetic modification of established antibacterial scaffolds. This review discusses contemporary chemical and biochemical strategies for combating antimicrobial resistance, with particular emphasis on chemical modification of antibiotic structures. Structural optimization of β-lactams, sulfonamides, fluoroquinolones, tetracyclines, macrolides, and glycopeptides can modify target interactions, improve stability against resistance mechanisms, enhance bacterial penetration, and potentially restore or extend antibacterial activity. The review also highlights antimicrobial peptides and their optimization through cyclization, terminal and side-chain modification, incorporation of non-proteinogenic amino acids, and nanoparticle-based formulation. In addition, genome mining, retro-biosynthetic approaches, semisynthetic engineering, and host-directed antimicrobial strategies provide complementary avenues for identifying and developing new therapeutic candidates. Collectively, these approaches demonstrate the important role of medicinal and synthetic chemistry in developing next-generation antibacterial agents and in extending the therapeutic potential of existing antibiotics. Continued integration of chemical innovation with microbiological, pharmacological, and clinical research will be essential for developing effective and sustainable solutions to the growing problem of antimicrobial resistance.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-14
DOI
https://doi.org/10.5281/zenodo.24216413
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Chemical Remodeling of Antimicrobials: Innovative Medicinal Chemistry Strategies to Combat Resistance

Vaishnavi Padale, Vijay Jagtap¹, Gayatri Athalekar
Zenodo (CERN European Organization for Nuclear Research)
Antibiotic Resistance in Bacteria
article

Chemical Remodeling of Antimicrobials: Innovative Medicinal Chemistry Strategies to Combat Resistance

Vaishnavi Padale, Vijay Jagtap¹, Gayatri Athalekar
article en

Abstract

Antimicrobial resistance (AMR) has emerged as a major global health challenge, reducing the effectiveness of conventional antibacterial therapies and limiting treatment options for bacterial infections. The continuous emergence of resistant microorganisms highlights the need for innovative approaches to discover new antibacterial agents and improve the activity of existing drugs. Medicinal chemistry and synthetic chemistry provide valuable strategies for addressing AMR through rational drug design, structural optimization, antibiotic adjuvants, combination therapy, drug repurposing, target-directed approaches, and semisynthetic modification of established antibacterial scaffolds. This review discusses contemporary chemical and biochemical strategies for combating antimicrobial resistance, with particular emphasis on chemical modification of antibiotic structures. Structural optimization of β-lactams, sulfonamides, fluoroquinolones, tetracyclines, macrolides, and glycopeptides can modify target interactions, improve stability against resistance mechanisms, enhance bacterial penetration, and potentially restore or extend antibacterial activity. The review also highlights antimicrobial peptides and their optimization through cyclization, terminal and side-chain modification, incorporation of non-proteinogenic amino acids, and nanoparticle-based formulation. In addition, genome mining, retro-biosynthetic approaches, semisynthetic engineering, and host-directed antimicrobial strategies provide complementary avenues for identifying and developing new therapeutic candidates. Collectively, these approaches demonstrate the important role of medicinal and synthetic chemistry in developing next-generation antibacterial agents and in extending the therapeutic potential of existing antibiotics. Continued integration of chemical innovation with microbiological, pharmacological, and clinical research will be essential for developing effective and sustainable solutions to the growing problem of antimicrobial resistance.

Zenodo (CERN European Organization for Nuclear Research)
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon